Biogen · Operating Cash Flow (Statement)

Latest reported$2.88Bperiod endingJun 30, 2026

BIIB Cash from Operations (-$7.50M → $2.88B)

Annual operating cash flow (statement)

High-resolution chart · PNG

BIIB operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	2,204,600,000
Dec 31, 2024	2,875,500,000
Dec 31, 2023	1,547,200,000
Dec 31, 2022	1,384,300,000
Dec 31, 2021	3,639,900,000
Dec 31, 2020	4,229,800,000
Dec 31, 2019	7,078,600,000
Dec 31, 2018	6,187,700,000
Dec 31, 2017	4,551,000,000
Dec 31, 2016	4,522,400,000
Dec 31, 2015	3,716,100,000
Dec 31, 2014	2,942,115,000
Dec 31, 2013	2,345,078,000
Dec 31, 2012	1,879,897,000
Dec 31, 2011	1,727,741,000
Dec 31, 2010	1,624,673,000
Dec 31, 2009	1,074,898,000
Dec 31, 2008	1,564,492,000
Dec 31, 2007	1,020,635,000
Dec 31, 2006	841,268,000
Dec 31, 2005	889,503,000
Dec 31, 2004	727,986,000
Dec 31, 2003	219,213,000
Dec 31, 2002	267,077,000
Dec 31, 2001	316,358,000
Dec 31, 2000	365,939,000
Dec 31, 1999	272,288,000
Dec 31, 1998	167,845,000
Dec 31, 1997	97,632,000
Dec 31, 1996	46,539,000
Dec 31, 1995	9,449,000
Dec 31, 1994	34,886,000
Dec 31, 1993	47,600,000
Dec 31, 1992	43,100,000
Dec 31, 1991	5,900,000
Dec 31, 1990	10,700,000
Dec 31, 1989	-7,500,000